Literature DB >> 21251599

Symptom management of affective and cognitive disturbance with a group of cancer survivors.

Graham J McDougall1, Heather Becker, Taylor W Acee, Phillip W Vaughan, Carol L Delville.   

Abstract

UNLABELLED: Cancer survivors 65 years of age and older experience treatment-induced memory impairments. However, clinicians do not intervene for these cognitive problems. This article describes the findings from a pilot study of a memory versus health training intervention and its adaptability for cancer survivors for symptom management. DESIGN AND METHODS: A convenience sample of older adults was enrolled in a longitudinal study of a memory and health training intervention and tested on five occasions for 2 years postintervention. The memory training was designed to increase cognitive performance, reduce anxiety, decrease negative attributions, promote health, and increase memory self-efficacy. In this analysis, we included change over time for the first four of the five data collection points. We calculated means and standard deviations on the memory measures for cancer survivors in the intervention (n = 8) and comparison (n = 14) groups. The analysis consisted of a mixed design analysis of variance comparing the two intervention groups across four periods for 12 months.
RESULTS: The typical cancer survivor in the sample was a 74-year-old Caucasian female; 14% were minorities. Because of the small sample, some of the effects were not statistically significant. Moderate to large effects were revealed in everyday and verbal memory performance scores, memory self-efficacy, strategy use, and memory complaints. There were also moderate effects for group-by-time interactions on the visual memory performance measure, the memory self-efficacy measure, the depression, the trait anxiety measure, and the complaints subscale. The memory intervention group tended to improve more than the health training group, although this was not always consistent. The results suggested that the participants benefited from the memory training intervention. IMPLICATIONS: Clinicians are often at a loss on how to intervene with cancer survivors who are experiencing cognitive problems following chemotherapy treatment. Evidenced-based interventions for this aspect of symptom management are almost nonexistent. The Cognitive Behavioral Model of Everyday Memory (CBMEM), derived from Self-Efficacy theory provides an evidence-based intervention for symptom management.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21251599      PMCID: PMC3057534          DOI: 10.1016/j.apnu.2010.05.004

Source DB:  PubMed          Journal:  Arch Psychiatr Nurs        ISSN: 0883-9417            Impact factor:   2.218


  33 in total

Review 1.  Cognitive interventions among older adults.

Authors:  G J McDougall
Journal:  Annu Rev Nurs Res       Date:  1999

2.  A preliminary study of the association between changes in mood and cognition in a mixed geriatric psychiatry sample.

Authors:  R H Benedict; M Dobraski; M Z Goldstein
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  1999-03       Impact factor: 4.077

3.  Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma.

Authors:  Tim A Ahles; Andrew J Saykin; Charlotte T Furstenberg; Bernard Cole; Leila A Mott; Karen Skalla; Marie B Whedon; Sarah Bivens; Tara Mitchell; E Robert Greenberg; Peter M Silberfarb
Journal:  J Clin Oncol       Date:  2002-01-15       Impact factor: 44.544

4.  Memory improvement program for elderly cancer survivors.

Authors:  G J McDougall
Journal:  Geriatr Nurs       Date:  2001 Jul-Aug       Impact factor: 2.361

5.  A metaanalysis of studies of the effects of cancer chemotherapy on various domains of cognitive function.

Authors:  Catherine E Jansen; Christine Miaskowski; Marylin Dodd; Glenna Dowling; Joel Kramer
Journal:  Cancer       Date:  2005-11-15       Impact factor: 6.860

6.  A new scale for the assessment of functional status in Alzheimer's disease and related disorders.

Authors:  D A Loewenstein; E Amigo; R Duara; A Guterman; D Hurwitz; N Berkowitz; F Wilkie; G Weinberg; B Black; B Gittelman
Journal:  J Gerontol       Date:  1989-07

Review 7.  Mild cognitive impairment after adjuvant chemotherapy in breast cancer patients--evaluation of appropriate research design and methodology to measure symptoms.

Authors:  Tomohiro Matsuda; Tomoko Takayama; Manabu Tashiro; Yu Nakamura; Yasuo Ohashi; Kojiro Shimozuma
Journal:  Breast Cancer       Date:  2005       Impact factor: 4.239

8.  Health-training intervention for community-dwelling elderly in the SeniorWISE Study.

Authors:  Graham J McDougall; Heather Becker; Taylor W Acee; Phillip W Vaughan; Keenan Pituch; Carol Delville
Journal:  Arch Psychiatr Nurs       Date:  2009-10-15       Impact factor: 2.218

9.  A framework for cognitive interventions targeting everyday memory performance and memory self-efficacy.

Authors:  Graham J McDougall
Journal:  Fam Community Health       Date:  2009 Jan-Mar

Review 10.  Cognitive impairment associated with chemotherapy for cancer: report of a workshop.

Authors:  Ian F Tannock; Tim A Ahles; Patricia A Ganz; Frits S Van Dam
Journal:  J Clin Oncol       Date:  2004-06-01       Impact factor: 44.544

View more
  15 in total

Review 1.  Embracing the complexity: Older adults with cancer-related cognitive decline-A Young International Society of Geriatric Oncology position paper.

Authors:  Mackenzi Pergolotti; Nicolò Matteo Luca Battisti; Lynne Padgett; Alix G Sleight; Maya Abdallah; Robin Newman; Kathleen Van Dyk; Kelley R Covington; Grant R Williams; Frederiek van den Bos; YaoYao Pollock; Elizabeth A Salerno; Allison Magnuson; Isabella F Gattás-Vernaglia; Tim A Ahles
Journal:  J Geriatr Oncol       Date:  2019-10-14       Impact factor: 3.599

Review 2.  Memory and cancer: a review of the literature.

Authors:  Graham J McDougall; JoAnn S Oliver; Forrest Scogin
Journal:  Arch Psychiatr Nurs       Date:  2014-03-22       Impact factor: 2.218

3.  Tibetan sound meditation for cognitive dysfunction: results of a randomized controlled pilot trial.

Authors:  K Milbury; A Chaoul; K Biegler; T Wangyal; A Spelman; C A Meyers; B Arun; J L Palmer; J Taylor; L Cohen
Journal:  Psychooncology       Date:  2013-05-09       Impact factor: 3.894

4.  The importance of symptom surveillance during follow-up care of leukemia, bladder, and colorectal cancer survivors.

Authors:  Erin E Kent; Sandra A Mitchell; Ingrid Oakley-Girvan; Neeraj K Arora
Journal:  Support Care Cancer       Date:  2013-09-10       Impact factor: 3.603

5.  Effects of compensatory cognitive training intervention for breast cancer patients undergoing chemotherapy: a pilot study.

Authors:  Jin-Hee Park; Yong Sik Jung; Ku Sang Kim; Sun Hyoung Bae
Journal:  Support Care Cancer       Date:  2017-01-28       Impact factor: 3.603

6.  Systematic review of self-reported cognitive function in cancer patients following chemotherapy treatment.

Authors:  Victoria J Bray; Haryana M Dhillon; Janette L Vardy
Journal:  J Cancer Surviv       Date:  2018-05-04       Impact factor: 4.442

Review 7.  Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults.

Authors:  Jeffrey S Wefel; Shelli R Kesler; Kyle R Noll; Sanne B Schagen
Journal:  CA Cancer J Clin       Date:  2014-12-05       Impact factor: 508.702

Review 8.  Cognitive Rehabilitation for Cognitive Dysfunction after Cancer and Cancer Treatment: Implications for Nursing Practice.

Authors:  Diane Von Ah; Adele Crouch
Journal:  Semin Oncol Nurs       Date:  2020-01-17       Impact factor: 2.315

Review 9.  Cognitive Function in Older Adults With Cancer: Assessment, Management, and Research Opportunities.

Authors:  Allison Magnuson; Tim Ahles; Bihong T Chen; Jeanne Mandelblatt; Michelle C Janelsins
Journal:  J Clin Oncol       Date:  2021-05-27       Impact factor: 50.717

Review 10.  Non-pharmacological interventions for cognitive impairment due to systemic cancer treatment.

Authors:  Charlene J Treanor; Una C McMenamin; Roisin F O'Neill; Chris R Cardwell; Mike J Clarke; Marie Cantwell; Michael Donnelly
Journal:  Cochrane Database Syst Rev       Date:  2016-08-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.